Philip Morris
the Nosology of Abuse and Dependence
Fields
- Author
- Kleber, H.D.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
1. /ifl,~ /tff.. va. 24. Supp. :. p0 5144, tM
frima0 u Grat firttaue.
002:11S6/9o 13 00 - 00
: 1970 pt.qmw Prat p+c
THE NOSOLOGY OF ABUSE AND DEPENDENCE
HERBERT D. KLEBER*
Yale University School of Medicine and the Dtrector. Substance Abuse Treatment Untt. Connecticut
Menul Health
Center. New Haven, Connecticut, U.S.A.
Summar,v-Phystctans who prescnbe benzodiazeputes often are asked by their patients if these drugs
might be addicting or have potential for abuse. Clarifying these concepts is difficult because of
numerous "gtay areas" of drug use and confusion over ttxdtcal cntena for such tetms as "addtcuon",
' depetdence". and "tolennce".
Many of the efforts to clarify the terminology regarding substance habrtuatton, abuse. and
addictton have resulted in addiuonaW confusion. They have resulted in overiapptng definitions of
abuse
and dependence. the injection of morai judgements into sctenttfic tams, and difficulty separaung the
diagnoses of the physical dependence tcaused by prolonged use of a wide vanety of drugs. many of
whtch are never abused) from that of phystcal dependence secondary to an abusive pattem of use.
This article will trace the history of the various definitions currently in use. and will suggest
newer
terminology to nsplace misleading or erroneous terms.
INTRODUCTION
I
I
In order to understand the nosological and conceptual confusion that physicians and patients
have in regard to certain properties of the benzodiazepine category of drugs. it is necessary to
clarify and discuss some of the historical and definitional aspects regarding drug use and abuse.
The current definition of misuse is the use of legitimately obtained drugs in a manner or
amount other than prescribed in order to produce a certain psychological state, such as the
use of a prescribed cough suppressant medication containing codeine to get high rather than
to suppress cough. -
This definition, however, can create confusion regarding the legitimate use of prescribed
drugs. For example. patients may use the prescribed medication to relieve symptoms other
than those for which it was originally prescribed, such as using sleeping pills during the day
to reduce anxiety.
Another issue in the interpretation of the term "misuse" concerns the source of the
medication: the drug may be used legitimately (to relieve insomnia). but be obtained
illegitimately (from a fnend rather than a physician).
HISTORICAL DEFINITIONS OF ABUSE
I
I
I
I
ZINBERG et al. ( 1978) have noted that "it was not until the early twentieth century that the
nonmedical use of certain substances"...became "a problem of drug abuse. evoking
enough...public concern to lead to legal regulation".
After the Civil War. morphine became associated with widespread addiction via
Address correspondence to Herbert D. Kleber. M.D.. Director, Substance Abuse Treatment Unit.
Connecticut Mental Health Lenter. 34 Park Street. New Haven, CT 06519. U.S.A.
57
I

I
I
I
I
I
I
I
I
I
I
1
I
I
I
58 HoteExr D. Kt.ESEit
nonmedical use. known as "the soldier's disease". However, this was regarded mainly as
evidence of character weakness, not of criminality. Up to the first decade of the twentieth
century, large amounts of opiates were used in patent medicines and apparently a higher rate
of opiate addiction existed at that time than exists now (LINDESMITH. 1965). BRECKER (1982)
noted that the predominantly rural. white women who suffered from opiate addiction were
viewed with pity rather than contempt.
MusTo (1973) has pointed out that the term "drug abuse" apparently was applied first to
the use of cocaine by Southern blacks early in the twentieth century and then to the
smoking of opium by Chinese Americans. In both cases. he believes this term represented
fear of a despised minority.
With the passage of the Harrison Narcotic Act in 1914, the use of heroin and morphine
was included in the term "drug abuse." In the next decades the use of unprescribed opiates
shifted. in the public mind. from a bad habit into a criminal activity (ZIyBERG et al., 1978).
At the same time, the meaning of "addiction" changed also. Addiction formerly meant a
habit, good as well as bad. In 1902. DR. CHARLES TowNs described a so-called "addictive
triad": increased craving, growing tolerance, and a withdrawal syndrome when the drug is
withheld (MusTO: 1973). By 1910 to 1920, the word had become linked to the culturally
disapproved use of certain drugs. Today the term usually refers to the physical dependence
following the continued and heavy use of opiates. barbiturates. or alcohol.
TowNs' concept of the "addictive triad" is more difficult to demonstrate medically than it
first appears. "It is difficult to define 'increased craving' (or the later version, 'overwhelming
need') precisely, or to limit those notions to drug abuse. The very choice of the term
'craving' indicates the subtle biases behind the definition. The adjectival form is 'craven.'
which means cowardly. Craving itself connotes disrepute. weakness, and a sense of
desperation that may lead to anti-social and even criminal behavior" (ZINBERG et al.. 1978).
The term "tolerance" is also not as simple as it first appears. "While there is a
physiologically increasing accommodation to a substance, the phenomenon of 'growing
tolerance' is not a straightforward one. The capacity of different individuals to deal with
different amounts of substances without development of tolerance has become obvious"
(ZtNBERG er al., 1978). It has been noted with regard to the benzodiazepines that personality
factors may be more important than dose in the development of withdrawal symptoms
during gradual reduction from diazepam (TYRER er al.. 1984). Those with withdrawal
symptoms had significantly greater lability, sensitivity, impulsiveness, and resourcelessness
than those without.
MEDICAL DEFINITIONS OF ABUSE
Medically, abuse is often defined as nonmedical use. Non-ntedical use may involve either
use of a medically sanctioned drug for a different purpose. e.g. use of a sleeping pill to
produce a drunken state or use of a drug that has no currently recognized medical purpose
(e.g. mescaline). Thus, the 1972 American Psychiatric Association definition of drug abuse
is noted below (GLASSCOTE tt al., 1972):
Drug abuse refers to "the illegal. nonmedical use of a limited number of substances. mot
of them drugs. which have properties of altering the mental state in ways that are considered
I

I
I
I
I
THE NOSOIOGY OF ABUSE AND DFlfNDENCE
5q
by social norms and defined by statute to be inappropriate, undesirable, harmful.
threatening, or. at a minimum, culture alien".
A more recent definition of drug abuse is the non-prescriptive use of psychoactive
chemicals to alter one's psychological state and, as a result of such alteration, the
individual, others around him/her. or society incur some harm.
The vagueness of the terms "misuse" and "abuse" led a recent World Health Organization
(WHO) Expert Committee to recommend that these terms be abolished and replaced with
Unsanctioned Use. Hazardous Use. Dysfunctional Use, and Harmful Use (Table 1).
TABLE 1. (WHOi Exrm coWMrnU DERnmoru OF ABUSE
I
I
I
I
I
I
I
I
I
I
I
I
Unsanctioned Use-Lise of a drug that is not approved by a
society or a group within that society. Who dtupproves should be
made clear when the term is used. The term implies the
acceptance of disapproval as a fact in its own nght, without
having to determine or justify its basts, e.g. certatn psychedelics.
Hazardous Use-Use of a drug that will probably lead to harmful
consequences for the user---etther to d,vsfunction or to harm.
This category essentially includes Ux idea of risky behavtor, e.g.
smoking I pack of cigarettes a day.
Dysfunctional Use-Ux of a drug that is leading to impaired
psychological or social funcuonrng (e.g. loss of )ob. or marital
problems .
Harmful Use-Use of a drug that is known to have caused the
particular person nssur damage or mental illness.
ADDICTION AND HABiTL'AT7Oti
All drug taking behaviors were related to TOWNS' triad initially. When it was no longer
possible to explain the use of substances that did not produce physical dependence in those
terms. the concept of psychological habituation was developed. In 1957. WHO published an
official definition that included both physiological and psychological habituation.
Drug addiction was defined by WHO as a state or period of chronic intoxication
produced by the repeated consumption of a drug (natural or synthetic). Its characteristics
include (1) an overpowering desire or need (compulsion) to continue taking the drug and to
obtain it by any means: (2) a tendency to increase the dose: (3) a psychic (psychologicali
and generally a physical dependence on the effects of the drug: and (4) detrimental effect on
the individual and/or society.
Drug habituation is a condition resulting from the repeated consumption of a drug. lts
characteristics include (t) a desire (but not a compulsion) to continue taking the drug for the
sense of improved well-being which it engenders: (2) little or no tendency to increase the
dose: (3) some degr-e of psychic dependence on the effect of the drug but absence of
physical dependence and hence of an abstinence syndrome: (4) detrimental effects. if any.
primarily on the individual.
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
EA HFJtafJt7 D. KLEaex
In the above definitions. habituation tended to be the definition of addiction minus the
aspects of physical dependence-namely craving, tolerance, and a withdrawal syndrome.
Addiction involved "compulsion" while habituation involved "desire". The difference
between the two lies in the strength of the seeking. and there was an implicit assumption
that physiologic addiction is more overpowering than psychological habituation. However.
it was soon noted that some individuals could be physically dependent on a drug without
compulsive use patterns and vice versa. The tendency of the withdrawal syndrome. or fear
of it. to "compel" drug seeking and drug use behavior clearly differed for the same drug in
different circumstances. For example, cocaine. which leads to less physiological
dependence than heroin. can have even greater "addicting" potential.
In 1964. WHO recognized sufficient additional flaws in the definitions and formed a new
expert committee, using the concept of "dependence" as its crucial variable (Table 2).
Dependence. either psychic or physical, or both, arose after periodic or continued use of a
particular drug. The characteristics varied with the drugs. Thus, persons with morphine-type
dependencies had both psychic and physical dependence. and persons with cannabis-type
(marijuana) drug dependencies had only psychic dependency.
The definitions relied on the same ambiguous and difficult concepts of psychic and
physical dependence abused earlier and also resulted in being used in a form of circular
reasoning. Thus, the definition of drug dependence which was developed to describe a
particular form or pattern of drug use became an explanatory concept: If the question of
why an individual was constantly using drugs was raised- the common answer was,
"Because they are dependent on drugs". Thus the term "drug dependence" had become per
se, the explanation of the pattern of drug use (ZtHaERC ef al.. 1978).
ABUSE AND DEPENDENCE DSM-IlI DEFINiT1OIvS
In 1980. the Diagnostic and Statistical Manual of Mental Disorders. Third Edition ( DSM-
I11) (1980) partially solved the difficulties with the concepts of psychic and physical
dependency by using two terms: abuse and dependence. Abuse was defined as including a
pathologic pattern of use. impaittnettt in social or occupational functioning, and duration of
TA&E 2. WoRw HEu-n+ oaoarmAnoN i WHO) t>efltr+navs. 1964
' Deug Dependence-A state of psychic or physical dependence. or both.
on a drng, ansing in a person following admtnistratron of that drug on a
penudtc or conttnuou.s basts. The charactensttcs of such a state will vary
with the agent involved.
Psychic Dependence-A condition in which a drug produces "a feeling
of satisfaction and a psychic drive that requires periodic or continuous
admtntsnanon of the drug to produce pleasure or to avoid dtscomfoct".
Physical Dependatce-An adapuve state that manifests itseif by inten-
sive physical disturbaxes when the administration of the drug is sus-
pended. These disturbances. i.e. the withdrawal or abstinence syn-
dtomes. are made up of specific arrays of symptoms and signs of both
psychic and physical nature that ast characteristic of each drug type.
I

7Iff NcsoLOOY oP AlusE AND DeFI1DFIJCE 61
I
I
I
I
I
I
I
I
I
I
I
I
I
the disturbance for at least one month. Dependence was defined as being manifested by
tolerance, withdnwal, or both.
Some drugs. e.g. opioids. sedatives, and amphetamines, had categories of both abuse and
dependence. Cocaine, which was not believed in 1980 to.cause tolerance or withdrawal, was
included only in the Abuse category while tobacco was included only in the Dependence
category. The full definitions of sedative abuse and dependence are in Table 3.
The DSM-III definitions of abuse and dependency, however, make no distinction between
dependence and legitimate, long-term medical use of an opiate or sedative which results in
TAat.E 3. DSM-tII o+AoMosnc cItrrEun Fott t,,vternrRArE on stMt>au.Y
ACTING sEDAnVE OR HYlT/OTK' ,R6usE
A. Fatum of patholoEicat use: inabihry to cutdown or stop use:
intoxrcuwn thra+ahout the day: fnaquent use of the equivailent of 600
mg or more of secobubital or 60 mg or more of ditzepam: amnestc
penods for events that occurred while intoxicated.
B. Impatrment in socul or occupattoeal functioning due to substaace
use: e.g. fighu. loss of frxrbs, absence from worle. loss of tob, or
legal difficulties (other than a single arrest due to possession.
purchase. or sale of the substance).
C. Duration of disturbutce of at least one month.
D. Tolerance: need for markedly increased amounts of the substance to
ochieve the desired effect. or markedly administered effect with
regulu use of the same atnowft.
E. Withdnwal: developtnent of barbutuate or similarly acting sedative or
hypnotic wtthdrawal after cessation of or teducuon in substance use.
tolerance and which, with abrupt cessation, is likely to result in withdrawal. Also under
DSM-III, opiate and sedative dependence with no abuse are considered psychiatric disorders:
whereas similar states related to chronic use of anti-hypertensive agents or tricyclic
antidepressants are not. In addition, there was no provision for severity of dependence.
These problems led to the changes found in the Diagnostic and Statistical Manual of
Mental Drsordtrs, Third Editiorr, Revised (DSM-II1-R) (1987) (Table 4). The Abuse and
Dependency categories have been abolished and the category of Substance Dependence has
been reestablished (with the exception of an Abuse residual category for individuals who
have never met the Dependence criteria). Of the nine items listed, three are necessary for
the diagnosis. and each is modified further as mild. moderate. or severe.
DEPENDENCE
Because of the problems in terminology not rectified by DSM-III. the WHO and ADAMHA
convened an International Working Group and in 1980 issued a report concerning the
terminology of drug dependence. They defined dependence as "a syndrome manifested by a
behavioral pattern in which the use of a given psychoactive drug or class of drugs is given a
~
~
N
CJt
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
62
HFJIBFJtT D. KLEBER
TABIF 4, BSM-IILR qAGNOSTK CRftERU FOR PsYC}IOACrtvE SUBSTANCE
pEPENDFliCE
A. At lezu three of the following must be prtsent.
I. Substance often taken in larger amounts or over a longer penod than
the person intended:
2. Persistent desire or one or more unsuccessful efforts to cut down or
control subuu-ce use.
3. A great deal of time spent in activities necessary to get the substance
(e.g. chain smoktng), or recovenng from its effects:
4. Frequent intoxication or withdrawal symptoms when expected to
fulfill ms,pr rote obligations at work, school, or home 'e.g. does not
go to work because hung over, goes to school or work "htgh".
intoxicated while taking care of his or her chtldren). or when
substance use is physicilly hazardous (e.g. dnves when tntozicatedl:
5. Important social. occupauortal, or rscrsauonal activities given up or
reduced because of substance use:
6. Continued substance use despite knowledge of having a persistent or
recurrent social. pcychologtcal, or physical problem that is cauxd or
- exacerbated by the use of the substance i e.g. keeps using herorn
despite family arguments about it. cocaine induced desxessrun, or has
an ulcer made worse by drtttktngl:
7 Mariced tolerance: need for tnarkedlv increased amouttu of the
substance ( t.e. at least a 50% trtcreaset in order to achieve
intoxication or desired effect: or markedly diminished effect with
continued use of the same 7lfrlolint:
Note. Tht followin,t items moY not app(Y to cannabis. hallucuwRens, or
phenc%rlydrRe r PG'P ):
S. Chanctenuic withdrawal symptoms (see specific withdrawal
syndromes under psychoactive substance tnduced organic merttal
dtsoniers ):
9. Substance often taken to relieve or to avoid withdrawal symptoms:
B. Some symptoms of the disturbance have persisted for at kast one
month, or have occurred rtpeatedly over a longer period of time.
much higher priority than other behaviors that were once at higher value...Not all the
components need always be present. or not always present with the same intensity....
"The dependence syndrome is not absolute but is a quantitative phenomenon existing in
degrees. The intensity of the syndrome is measured by the behaviors that are elicited in
relation to using the drug, and by the other behaviors that occur secondary to drug use...No
sharp cut-off point can be identified for distinguishing drug dependence from non-
dependent but recurrent drug use." At the extreme the "dependence syndrome is associated
with compulsive drug using behavior".
The word "dependence" tends to be used in the scientific literature to convey two
different ideas: (1) A behavioral syndrome that implies corttpulsi ve. out of control use, and
(2) physical dependence. or, alterations in neural systems manifested in tolerance and in
withdrawal when the chronically administered drug is discontinued or displaced from its
receptor. Unfortunately, this dual use of the word dependence leads to both semantic and
conceptual confusion. No close parallel exists between the capacity of a drug to produce
I

i
I
I
I
I
I
I
I
T¢ (VOSOLOGY Oi AaUSf ,wo DM-*roe4cE 6a
tolerance and its reinforcement potential. Thus. the International Working Group
recommended restricting the term "dependence" to the beh,avioral syndrome prevlousl-~
described and substituting the tettn, "neuro-adaptation" for physical dependence. It is of
interest that the chronic use of many drugs, including tricyclic anti-depressants and beta-
adrenergic blockers, brings about neuro-adaptive changes. Abrupt discontinuation of these
is followed by withdrawal phenomenon, but not by drug seeking behavior.
Specific patterns of benzodiazepine dependence have been proposed (LAux et al.. 1984).
Unfortunately, these proposals are often simplistic, confuse tolerance and physical
withdrawal with dependence, and ignore the evidence that high dose dependency can be
either similar to low dose dependency or episodic and binge-like. The proposed patterns are
as follows.
Benzodiazepine prinwry low-dose dependency at therapeutic dosage
The extent of primary low dose dependency has been recognized only recently. In addition
to case reports of mild abstinence syndromes, reports of a few controlled trials of
benzodiazepine withdrawal from therapeutic doses have been published (BusTO et al..
1986).
Benzodiazepine primary high-dose dependency
Patients who develop primary high dose dependency usually take two to five times the
normal therapeutic dosage (LAUX et al.. 1984). With the higher dosage. physical
dependence can develop within three weeks. In most cases. however. the drugs have been
taken for years. Patients with this type of dependency are at greater risk of developing toxic
benzodiazepine syndromes and severe withdrawal reactions (MARKS, 1978).
Benzodiettpine secondory dependency (multiple drug abuse)
Secondary dependency arises in the context of multiple drug abuse and/or alcoholism. Some
authors claim that these cases are much more frequent than primary benzodiazepine
dependency. emphasizing the high frequency of alcohol abuse.
MARKS (1983) suggests that it is more helpful to refer to "withdrawal reactions" rather
than to "dependence" in relation to the benzodiazepines. In studies in which therapeutic
doses are abruptly stopped. the key variables in determining whether withdrawal symptoms
occur appear to be those of duration of use and personality. At less than four months of use
of benzodiazepines. the incidence is "virtually nil unless alcohol, other sedatives or opiates
are also being taken(Bus7o et al., 1986). The incidence of significant withdrawal
symptoms is less than 5% after one year. but after longer than one year it appears to rise
sharply. TYRER (1984) notes that individuals taking the drugs for psychiatric problems are
more likely to experience withdrawal symptoms than those using them for neurological
purposes (e.g. seizure disorders or spasticity). Some patients may stop the benzodiazepines
abruptly without withdrawal symptoms because they feel they no longer need the effect.
Others, particularly panic disorder patients. may be unable or unwilling to stop the
medications because of fear of losing the therapeutic effect and re-experiencing unpleasant
psychological symptoms, although no withdrawal symptoms are likely to occur. The same

I
I
I
I
I
I
I
I
I
I
1
I
I
I
64 HERDEJtT D. KLEDER
category of drug may be (I) used but not abused and without physical dependence. (2) used
but not abused and with physical dependence, (3) abused without physical dependence (as
in a binge pattern of use). (4) abused with physical dependence.
CONCLUSION
Many of the attempts to define the concepts of dnug habituation, abuse, and addiction have
resulted in additional confusion. The confusion is a result of overlapping definitions of abuse
and dependence, injection of moral ideas into scientific terms, and difficulty in separating a
diagnosis of physical dependence caused by prolonged use of a wide variety of drugs-matty of
which are never abused-,and the physical dependence secondary to an abusive pattern of use.
In regard to the benzodiazepine-type drugs, some patients may use the drug (1) at usual
therapeutic doses for relief of anxiety or depression and not display withdrawal symptoms
even on abrupt cessation: (2) as above but display withdrawal symptoms with abrupt
withdrawal or even with gradual withdrawal; (3) periodically for a"high," especially
combined with alcohol: (4) regularly at high doses for a chronic drunk and manifest
withdrawal symptoms on abrupt stopping.
REFERENCES
BRECHER. E. M.. & THE EDtTORS OF COwSUMER REPORrS. (1972) LJcJt and Illicit DrYts' The Consumers
Lnton
Guide to Drae Ahuse Boston Ltttle. Brown Co.
BLSTO. L.. SELLE1t5. E. M.. NARA%JO. C. A.. CAMELL. H.. SANCHEZCRAJS. M.. & SYUORA. K. (1986)
Withdrawal
reaction after longterm therapeutic use of benzodtazepmes. N Engl. J. Med. 315. 854-859.
Dtatnnsric & Stattsru'al Manuai of Mental DJsorders. Third Eduton. (1980) Washtngton. D,C.: American
Psychtatnc Assocuuon.
Dtagnosttc & Stattstrcal Manual o/ Mtntal Dtsordtrs. Third Editron. Rtrtsed. (1987) Washington.
D.C.: Amerscan
Psychiatric Associauon,
GLASSCOTE. R. M.. SUSSEx. J. N.. JAFFE. 1. H.. BALL. J.. & BRU.L. L. (1972) The Treatment of Drug
Abuse
Pr»Rrams. Prohltms. Prosptcts Washington. D.C.: American Psychutttic Assoctation.
LALx. G.. & PLRYE..R. D. A. (1984) Benzodiazepines-mtsuse, abuse and dependency. Am. Fam Phvstcran
30.
139147.
LJNDEsMtTH. A. R. (1965) The Addict & the Law' Bloomington. Indiana: Indwta University Press.
M..RKS.1. (1978) TThe Brncodtaceptnts. Usr. Orerust. Misuse. Ahtve. Lancaster. England: MTP Press.
M..RKS.1. (1983) The benzodiazepmes: an international perspective. J Psvchoactivt Drurs 15. 137
148,
Mtaro. D. F. (1973) The Amerre an Disease. OrttJns of Narcotic Controls. New Haven. Conn: Yak
Untversttv Press.
TYRER. P. J.. & SElvEwRIGHT. ,1. (19g4) Identification and management of benzodtaZeplne dependence.
POsrqrad
Med J 60 ( suppl 2). 41-46.
ZJNeERC. N. E.. HAROtNC. W. M.. & Arst.ER. R. (1978) What is drug abuse? J. DrvR Issues 8. 935.
I
